These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20577127)

  • 21. Calcineurin inhibitor-induced headache: clinical characteristics and possible mechanisms.
    Ferrari U; Empl M; Kim KS; Sostak P; Förderreuther S; Straube A
    Headache; 2005 Mar; 45(3):211-4. PubMed ID: 15836594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
    Neal DA; Gimson AE; Gibbs P; Alexander GJ
    Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CARI guidelines. Calcineurin inhibitors in renal transplantation: nephrotoxicity and calcineurin inhibitors.
    Coates PT;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S85-7. PubMed ID: 17316286
    [No Abstract]   [Full Text] [Related]  

  • 24. ACE gene D/D genotype as a risk factor for chronic nephrotoxicity from calcineurin inhibitors in liver transplant recipients.
    Gallon L; Akalin E; Lynch P; Rothberg L; Parker M; Schiano T; Abecassis M; Murphy B
    Transplantation; 2006 Feb; 81(3):463-8. PubMed ID: 16477235
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
    Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
    Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated sympathetic nerve activity in patients with accelerated essential hypertension.
    Matsukawa T; Mano T; Gotoh E; Ishii M
    J Clin Invest; 1993 Jul; 92(1):25-8. PubMed ID: 8325991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypomagnesia and arrhythmia corrected by replacing cyclosporine with FK506 in a heart transplant recipient.
    Ko WJ; Lin FL; Wang SS; Chu SH
    J Heart Lung Transplant; 1997 Sep; 16(9):980-2. PubMed ID: 9322151
    [No Abstract]   [Full Text] [Related]  

  • 28. The CARI guidelines. Calcineurin inhibitors in renal transplantation: pregnancy, lactation and calcineurin inhibitors.
    Grimer M;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S98-S105. PubMed ID: 17316288
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute rejection and heart infection rates in FK 506- versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study.
    Arbustini E; Dal Bello B; Rinaldi M; Diegoli M; Grasso M; Pellegrini C; Morbini P; Martinelli L; Bonora MR; Viganò M
    J Heart Lung Transplant; 1997 Sep; 16(9):982-4. PubMed ID: 9322152
    [No Abstract]   [Full Text] [Related]  

  • 30. Chronic salt loading and cardiovascular-associated changes in experimental diabetes in rats.
    Maeda C; Schaan B; Oliveira E; Oliveira V; De Angelis K; Irigoyen M
    Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):574-80. PubMed ID: 17581211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Is it possible to prevent kidney problems caused by immunosuppression?].
    Aitio ML
    Duodecim; 2000; 116(5):511-9. PubMed ID: 11787104
    [No Abstract]   [Full Text] [Related]  

  • 32. Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence.
    Vivarelli M; Cucchetti A; La Barba G; Ravaioli M; Del Gaudio M; Lauro A; Grazi GL; Pinna AD
    Ann Surg; 2008 Nov; 248(5):857-62. PubMed ID: 18948815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
    Chapman JR; Nankivell BJ
    Nephrol Dial Transplant; 2006 Aug; 21(8):2060-3. PubMed ID: 16728428
    [No Abstract]   [Full Text] [Related]  

  • 34. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF; Molina E; Romero R; Otero E; Tomé S; Varo E
    Liver Transpl; 2009 Dec; 15(12):1792-7. PubMed ID: 19938140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of calcineurin inhibitors on survival and histologic disease severity in HCV-infected liver transplant recipients.
    Berenguer M; Aguilera V; Prieto M; San Juan F; Rayón JM; Benlloch S; Berenguer J
    Liver Transpl; 2006 May; 12(5):762-7. PubMed ID: 16528713
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potentiated sympathetic and hemodynamic responses to alcohol in hypertensive vs. normotensive individuals.
    Hering D; Kucharska W; Kara T; Somers VK; Narkiewicz K
    J Hypertens; 2011 Mar; 29(3):537-41. PubMed ID: 21252702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
    Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
    Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation.
    Scherrer U; Vissing SF; Morgan BJ; Rollins JA; Tindall RS; Ring S; Hanson P; Mohanty PK; Victor RG
    N Engl J Med; 1990 Sep; 323(11):693-9. PubMed ID: 2388667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Six-month cardiovascular changes in cyclosporine-treated recipients of corneal grafts: serial baroreflex responses.
    Bouhaddi M; Delbosc B; Fortrat JO; Henriet MT; Cappelle S; Ducloux D; Chalopin JM; Regnard J
    Transpl Int; 2004 Jul; 17(6):325-33. PubMed ID: 15221126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.